In a patient with stage IVB thyroid cancer with lung metastases, who has had a total thyroidectomy and radioactive iodine therapy, and is currently on dabrafenib and trametinib, is there a role for additional radioiodine therapy?
Abstract
The use of dabrafenib and trametinib may enable additional radioiodine therapy in radioiodine-refractory thyroid cancer with the BRAF V600E mutation, but further validation is required.
Fields of Study & Subjects
Thyroid Cancer Diagnosis and Treatment
Thyroid Disorders and Treatments
Thyroid and Parathyroid Surgery
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 8 February 2026